Insulin resistance, hyperglycemia, and atherosclerosis.

[1]  A. Tall,et al.  Impaired MEK Signaling and SERCA Expression Promote ER Stress and Apoptosis in Insulin-Resistant Macrophages and Are Reversed by Exenatide Treatment , 2012, Diabetes.

[2]  M. Andrassy,et al.  Deletion of bone marrow‐derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression , 2011, European journal of clinical investigation.

[3]  P. Tobias,et al.  Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. , 2011, Cytokine.

[4]  R. Ramasamy,et al.  Human Aldose Reductase Expression Accelerates Atherosclerosis in Diabetic Apolipoprotein E−/− Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[5]  I. Tabas.  Pulling down the plug on atherosclerosis: Finding the culprit in your heart , 2011, Nature Medicine.

[6]  M. Lopes-Virella,et al.  Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice. , 2011, The Journal of endocrinology.

[7]  E. Fisher,et al.  Diabetes Adversely Affects Macrophages During Atherosclerotic Plaque Regression in Mice , 2011, Diabetes.

[8]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[9]  K. Moore,et al.  Macrophages in the Pathogenesis of Atherosclerosis , 2011, Cell.

[10]  Michael E. Miller,et al.  Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .

[11]  D. Fryburg,et al.  Atherosclerosis Drug Development in Jeopardy: The Need for Predictive Biomarkers of Treatment Response , 2011, Science Translational Medicine.

[12]  D. Ron,et al.  Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress , 2011, Nature Cell Biology.

[13]  M. Copetti,et al.  The ENPP1 Q121 Variant Predicts Major Cardiovascular Events in High-Risk Individuals , 2011, Diabetes.

[14]  S. Moss,et al.  Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation. , 2011, Endocrinology.

[15]  E. K. Weir,et al.  Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[16]  R. Weisbrod,et al.  Abstract 13743: Upregulation of Nox4 by TGF{beta}1 Oxidizes SERCA the C674 Thiol and Inhibits Nitric Oxide in Arterial Smooth Muscle of the Prediabetic Zucker Rat , 2010 .

[17]  J. Schneider,et al.  De Novo Lipogenesis Maintains Vascular Homeostasis through Endothelial Nitric-oxide Synthase (eNOS) Palmitoylation*♦ , 2010, The Journal of Biological Chemistry.

[18]  T. Mazzone.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data. , 2010, Circulation.

[19]  K. Moore,et al.  Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.

[20]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[21]  SergiySukhanov,et al.  Smooth Muscle Cell–Specific Insulin-Like Growth Factor-1 Overexpression in Apoe−/− Mice Does Not Alter Atherosclerotic Plaque Burden but Increases Features of Plaque Stability , 2010 .

[22]  P. Delafontaine,et al.  Smooth Muscle Cell-Specific Insulin-Like Growth Factor-1 Overexpression in Apoe−/− Mice Does Not Alter Atherosclerotic Plaque Burden but Increases Features of Plaque Stability , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[23]  O. Morel,et al.  Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis. , 2010, Atherosclerosis.

[24]  M. Kitakaze,et al.  The Role of Endoplasmic Reticulum Stress in the Progression of Atherosclerosis , 2010 .

[25]  Christian Gieger,et al.  Edinburgh Research Explorer Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways , 2010 .

[26]  D. Bruemmer,et al.  Intensive glycemic control and cardiovascular disease: an update , 2010, Nature Reviews Cardiology.

[27]  G. Werstuck,et al.  Diabetes, hyperglycemia and accelerated atherosclerosis: evidence supporting a role for endoplasmic reticulum (ER) stress signaling. , 2010, Cardiovascular & hematological disorders drug targets.

[28]  F. Marotta,et al.  Progression of atherosclerotic lesions in the arteries and related gene expression: protective effect of phytonutrients. , 2010, Rejuvenation research.

[29]  C. Kahn,et al.  Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. , 2010, Cell metabolism.

[30]  G. King,et al.  Activation of protein kinase C isoforms and its impact on diabetic complications. , 2010, Circulation research.

[31]  L. Rodríguez-Mañas,et al.  Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo , 2010, PloS one.

[32]  V. D’Agati,et al.  Activation of the ROCK1 Branch of the Transforming Growth Factor-&bgr; Pathway Contributes to RAGE-Dependent Acceleration of Atherosclerosis in Diabetic ApoE-Null Mice , 2010, Circulation research.

[33]  R. DeFronzo.  Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 , 2010, Diabetologia.

[34]  C. Kahn,et al.  Insulin and Insulin-like Growth Factor-1 Receptors Act as Ligand-specific Amplitude Modulators of a Common Pathway Regulating Gene Transcription* , 2010, The Journal of Biological Chemistry.

[35]  Robert Langer,et al.  Spatiotemporal controlled delivery of nanoparticles to injured vasculature , 2010, Proceedings of the National Academy of Sciences.

[36]  D. Accili,et al.  The Impact of Macrophage Insulin Resistance on Advanced Atherosclerotic Plaque Progression , 2010, Circulation research.

[37]  I. Tabas.  Macrophage death and defective inflammation resolution in atherosclerosis , 2010, Nature Reviews Immunology.

[38]  M. Cooper,et al.  The RAGE Axis : A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature , 2010 .

[39]  C. Fernández-Hernando,et al.  Absence of Akt1 Reduces Vascular Smooth Muscle Cell Migration and Survival and Induces Features of Plaque Vulnerability and Cardiac Dysfunction During Atherosclerosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Brian C. Pridgen,et al.  Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet , 2009, Circulation research.

[41]  S. Watkins,et al.  Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis , 2009, Nature Medicine.

[42]  A. Bhatnagar,et al.  Aldose Reductase Protects Against Early Atherosclerotic Lesion Formation in Apolipoprotein E–Null Mice , 2009, Circulation research.

[43]  D. Hafler,et al.  Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells1 , 2009, The Journal of Immunology.

[44]  S. Yokoyama,et al.  On the mechanism for PPAR agonists to enhance ABCA1 gene expression. , 2009, Atherosclerosis.

[45]  M. Birnbaum,et al.  Contribution of Insulin and Akt1 Signaling to Endothelial Nitric Oxide Synthase in the Regulation of Endothelial Function and Blood Pressure , 2009, Circulation Research.

[46]  Araceli Arellano-Plancarte,et al.  Angiotensin II and the development of insulin resistance: Implications for diabetes , 2009, Molecular and Cellular Endocrinology.

[47]  Y. Zou,et al.  Mice deficient in PKC β and apolipoprotein E display decreased atherosclerosis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  K. Griendling,et al.  Insulin-Like Growth Factor-1 Receptor Expression Masks the Antiinflammatory and Glucose Uptake Capacity of Insulin in Vascular Smooth Muscle Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[49]  F. Ovalle.  10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes , 2009 .

[50]  Alexander S. Banks,et al.  Forkhead Transcription Factors (FoxOs) Promote Apoptosis of Insulin-Resistant Macrophages During Cholesterol-Induced Endoplasmic Reticulum Stress , 2008, Diabetes.

[51]  R. Roeder,et al.  Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia , 2008, The Journal of Experimental Medicine.

[52]  Merlin C. Thomas,et al.  Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes , 2008, Diabetes.

[53]  T. Littlewood,et al.  Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3* , 2008, Journal of Biological Chemistry.

[54]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[55]  C. Ayers,et al.  Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus , 2008, Circulation.

[56]  Alfonso T. Perez,et al.  Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus , 2008, Circulation.

[57]  A. Chait,et al.  Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice , 2008, Proceedings of the National Academy of Sciences.

[58]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[59]  R. Ramasamy,et al.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. , 2008, The Journal of clinical investigation.

[60]  A. Levy,et al.  Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype: A Prospective Double-Blinded Clinical Trial , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[61]  M. Birnbaum,et al.  Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. , 2007, Cell metabolism.

[62]  I. Kola,et al.  Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice , 2007, Circulation.

[63]  K. Bornfeldt,et al.  Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques? , 2007, Circulation research.

[64]  M. Fisher,et al.  Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) , 2007 .

[65]  G. Moneta,et al.  Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes , 2007 .

[66]  Xianlin Han,et al.  Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death Published, JLR Papers in Press, September 7, 2006. , 2006, Journal of Lipid Research.

[67]  A. Callow.  Cardiovascular disease 2005--the global picture. , 2006, Vascular pharmacology.

[68]  H. Arnqvist,et al.  Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[69]  E. Ur,et al.  The obesity epidemic and its cardiovascular consequences , 2006, Current opinion in cardiology.

[70]  Jiali Gu,et al.  Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. , 2006, Endocrinology.

[71]  C. Kahn,et al.  Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. , 2006, Cell metabolism.

[72]  D. Accili,et al.  Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. , 2006, Cell metabolism.

[73]  Erland Erdmann,et al.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial , 2005, The Lancet.

[74]  A. Tall,et al.  Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. , 2005, The Journal of clinical investigation.

[75]  R. Alexander,et al.  Mechanisms of Reactive Oxygen Species–Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[76]  E. Fisher,et al.  Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? , 2005, Current opinion in clinical nutrition and metabolic care.

[77]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[78]  A. Chait,et al.  Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. , 2004, The Journal of clinical investigation.

[79]  R. Virmani,et al.  Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics: A Postmortem Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[80]  T. Hughes,et al.  Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products , 2004, Diabetologia.

[81]  D. Accili,et al.  Increased CD36 protein as a response to defective insulin signaling in macrophages. , 2004, The Journal of clinical investigation.

[82]  K. Reue,et al.  Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[83]  C. Kahn,et al.  The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. , 2003, The Journal of clinical investigation.

[84]  Renu Virmani,et al.  Vulnerable plaque: the pathology of unstable coronary lesions. , 2002, Journal of interventional cardiology.

[85]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[86]  A. M. Lefer,et al.  Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. , 2002, Diabetes.

[87]  R. Natarajan,et al.  Diabetes-induced accelerated atherosclerosis in swine. , 2001, Diabetes.

[88]  L. Suzuki,et al.  Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. , 2001, Diabetes.

[89]  Y. Kido,et al.  The Insulin Receptor and Its Cellular Targets , 2001 .

[90]  Y. Kido,et al.  Clinical review 125: The insulin receptor and its cellular targets. , 2001, The Journal of clinical endocrinology and metabolism.

[91]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[92]  M. White,et al.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. , 1999, The Journal of clinical investigation.

[93]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[94]  P. Reaven,et al.  Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[95]  D. L. Wilson,et al.  Increased atherosclerosis in streptozotocin-induced diabetic mice. , 1996, The Journal of clinical investigation.

[96]  R. Henry.  Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus. , 1996, Annals of internal medicine.

[97]  S. Genuth,et al.  Forum One: Current Recommendations about Intensification of Metabolic Control in Non-Insulin-dependent Diabetes Mellitus , 1996, Annals of Internal Medicine.

[98]  D. Moller,et al.  Differential Regulation of Glucose Transport and Transporters by Glucose in Vascular Endothelial and Smooth Muscle Cells , 1993, Diabetes.